D

DeckTherapeutics, Inc.

4 employees

DeckTherapeutics specializes in acute omega-3 fatty acid therapeutics for neuroprotection.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cerebral palsy
Neuroprotection
Neonatal
Hypoxic-ischemic injury
Diglyceride
Epilepsy
Omega-3
Rare pediatric disease
Orphan drugs
Chemical
Therapeutics
EPA
DHA
Hypoxia-ischemia

Date founded

2019

FAQ